This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Toxic epidermal necrolysis (TEN) is a devastating full-thickness epidermal exfoliative disease caused by an inciting medication.¹ Clinical evidence of the disease usually presents 1 to 2 weeks after administration of the inciting medication. However, upon reexposure to a medication that previously caused TEN or exposure to a structurally related compound, the subsequent reaction is fulminant, is more severe, and may occur after the first dose.² Although TEN has been documented after exposure to quinolones, the incidence is very low.³

Report of a Case

A 52-year-old woman presented with the complaint of erythematous rash. The patient had taken only 1 dose (100 mg) of trovafloxacin (Trovan; Pfizer Inc, New York, NY) for sinusitis 24 hours prior to the development of symptoms. At the time of her admission, she was noted to have a diffuse, erythematous rash, scattered bullae, and large areas of desquamation involving the chest, abdomen, and extremities. Findings in skin biopsy specimens obtained . . . [Full Text of this Article]

Comment

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Norfloxacin-Induced Toxic Epidermal Necrolysis
Sahin et al.
The Annals of Pharmacotherapy 2005;39:768-770.
ABSTRACT | FULL TEXT